Dura Vermeer start met de bouw van het nieuwe Genmab Research and Development center
29 januari 2016

De nieuwe onderzoeksfaciliteit van 11.250 m² op het Utrecht Science Park, bestaat uit kantoren, laboratoria en faciliterende ruimtes zoals een science café, plaza en een auditorium.

GenDx opens new subsidiary in Baltimore MD
28 januari 2016

Today, GenDx Products Inc has opened a new subsidiary at the bwtech@UMBC Research and Technology Park South in Baltimore. At the new location order handling, logistics and first line support for the USA customers will be coordinated. The USA subsidiary will also keep stock of the full product portfolio for Sequencing based HLA typing by Sanger sequencing (SBTexcellerator®, AlleleSEQR®)and Next Generation Sequencing (NGSgo® for Illumina, IonTorrent and PacBio) as well for the transplant monitoring product (AlleleSEQR®, KMRtype® and KMRtrack®).

Internationale acquisitie levert tientallen miljoenen op
27 januari 2016

De provincie Utrecht heeft in 2015 ruim 84 miljoen euro aan buitenlandse investeringen weten binnen te halen. De acquisitieactiviteiten worden uitgevoerd onder de naam Invest Utrecht, om goed vindbaar te zijn voor potentiële investeerders. Invest Utrecht werkt nauw samen met de gemeenten en andere relevante partners (Economic Board Utrecht, Utrecht Science Park, Dutch Game Garden etc.).

Merus pulls forward target date for solid tumor data, reiterates intent to file IPO
26 januari 2016

Merus has shaved months off the date on which it expects to release data from a Phase I/II trial of its lead bispecific antibody in HER2-expressing solid tumors. The Dutch immuno-oncology player, which lists Johnson & Johnson ($JNJ), Novartis ($NVS) and Pfizer ($PFE) among its investors, provided the new timeline in an update to the paperwork it filed ahead of a planned Nasdaq IPO.

GenDx obtains CE-IVD marking for AlleleSEQR® HLA products
8 januari 2016

GenDx has obtained CE marking for the entire AlleleSEQR® product line for HLA sequencing based typing. The products are added to the growing list of CE-marked products like SBTexcellerator®, NGSgo® and SBTengine®, already applied for years. The CE marking will enable HLA typing laboratories to continue to comply with the guidelines for the use of CE-IVD marked AlleleSEQR® products. It also enforces the quality of the GenDx product portfolio to further increase its support to academic institutes and laboratories involved in solid organ or stem cell transplantations.

Merus and Gustave Roussy Form Strategic Collaboration to Develop Innovative Bispecific Antibodies for Therapeutic Immuno-Oncology Applications
4 januari 2016

UTRECHT, The Netherlands and VILLEJUIF, France, Jan. 04, 2016 (GLOBE NEWSWIRE) -- Merus B.V., a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, and Institut Gustave Roussy, a leading Comprehensive Cancer Centre in Europe, today announced entry into a strategic collaboration to jointly develop bispecific antibodies for therapeutic immuno-oncology applications.

Utrecht Science Park De Uithof in 2016 makkelijker bereikbaar met de bus
29 december 2015

Lokaal vervoerder U-OV heeft de openbaar vervoersplannen voor 2016 bekend gemaakt. Het OV gaat er iets anders uit zien door de komst van de Dichtersbaan en de in gebruik name van het busstation Jaarbeurszijde. Ook gaat er flink ingezet worden op de ontlasting van de overvolle lijn 12 richting De Uithof.